| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06299761 | Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications | COMPLETED | PHASE1 | 2024-03-28 | 2025-06-25 | 2025-06-25 |
| NCT05827614 | Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications | RECRUITING | PHASE1 | 2023-03-24 | 2027-03-31 | 2026-09-30 |